PGbioFect 3000plus

PGbioFect 3000Plus Transfection Reagent is an advanced nanoparticle-based transfection reagent designed for high-efficiency delivery of DNA, RNA, and RNAi into a wide variety of mammalian cell lines, including challenging cell types such as HEK293, HeLa, and SW480. Enhanced with the proprietary T3000 Transfection Booster, it provides significantly improved transfection efficiency over the standard PGbioFect 3000 reagent while maintaining low cytotoxicity and high cell viability. The optimized formulation enables robust transfection in serum-containing media without the need for a medium replacement step, simplifying experimental workflows, reducing handling time, and delivering reliable, reproducible results across diverse research applications.

Inquiry

Overview
Video
Documents
Recommended

Product Introduction of PGbioFect 3000Plus Transfection Reagent

In biomedical and biotechnological research, cell transfection serves as a critical link between basic research and translational applications, underpinning gene function exploration, drug development and disease mechanism dissection. High-performance transfection reagents determine experimental outcomes, and PGbioFect 3000Plus Transfection Reagent is developed to address such research demands, delivering an optimized transfection solution powered by cutting-edge formulations and robust technical performance.

1. Advanced Nanoparticle Technology for Reliable Transfection Performance

Integrated with innovative nanoparticle technology, PGbioFect 3000Plus can form stable compounds with exogenous nucleic acids (DNA and RNA). Owing to ultra-small particle size and large specific surface area, the nucleic acid-nanoparticle complexes protect payloads from intracellular nuclease degradation, and interact with cell membranes via unique physicochemical properties to boost transmembrane delivery efficiency and achieve precise intracellular nucleic acid release.

This core technology enhances experimental accuracy and data reproducibility, enabling steady exogenous gene expression across batches. It minimizes experimental deviation and provides credible results for high-standard biomedical research.

2. Core Superior Characteristics & Wide Applicability

(1) High Transfection Efficiency

Combining proprietary formulations with nanoparticle engineering, PGbioFect 3000Plus enables rapid binding to cell membranes and efficient intracellular delivery of nucleic acid complexes. It adapts well to mainstream cell lines with stable transfection efficacy.

It delivers robust transfection performance in widely used research models, including HEK293 cells for gene expression research, SW480 colorectal cancer cells, HepG2 hepatocytes, LNCaP prostate cancer cells, P19 embryonic stem cells and HeLa tumor cells. It supports phenotypic and mechanistic research covering oncology, hepatology, neurobiology and embryonic development.

(2) Ultra-Low Cytotoxicity

Nanoparticle composition and surface properties are fully optimized to reduce cytotoxicity to an ultra-low level. The reagent interacts mildly with host cells without disrupting cellular physiological activities, maintaining high cell viability and proliferation capacity post-transfection.

This advantage is essential for long-term cell culture and signal pathway research. It avoids cell apoptosis and physiological dysfunction induced by cytotoxic transfection reagents, eliminating result distortion and ensuring uninterrupted cell-based assays.

(3) Cell Viability Enhancement

Beyond low cytotoxicity, specific functional components of PGbioFect 3000Plus optimize the intracellular microenvironment and facilitate cellular metabolism. Post-transfection cells maintain normal morphology and accelerated proliferation. For stem cell research, the reagent preserves stem cell viability and pluripotency, acting as a reliable tool for regenerative medicine and stem cell therapy studies.

3. T3000 Enhancer Enables Transfection of Hard-to-Transfect Cells

Compared with the basic PGbioFect 3000 version, PGbioFect 3000Plus is supplemented with T3000 transfection enhancer. T3000 modifies nanoparticle-nucleic acid complexes to strengthen membrane binding, overcoming physiological barriers including special membrane structures, abnormal surface charges and low receptor expression of refractory cell types.

Validated by massive assay data, T3000 integration greatly lifts transfection efficiency of hard-to-transfect cells, breaking technical bottlenecks for challenging cell research and expanding research boundaries for life science laboratories.

4. Competitive Advantages vs. Commercially Available Reagents

(1) Tailored Optimization for Refractory Cell Transfection

Most commercial transfection reagents show poor activity against hard-to-transfect cells. Our R&D team optimized nanoparticle surface modification and formulations based on membrane characteristics of refractory cells. Notably, PGbioFect 3000Plus realizes efficient transfection of primary cells, which are insensitive to traditional reagents, facilitating primary cell physiological and pathological mechanism research.

(2) Negligible Cytotoxicity and Medium-Change-Free Operation

PGbioFect 3000Plus exhibits superior biocompatibility and lower cytotoxicity than competing products. Different from conventional reagents that trigger cellular damage and viability decline, it ensures mild transfection reactions. Benefiting from excellent biocompatibility, medium replacement is unnecessary after transfection. This operation simplifies experimental workflows, cuts contamination risks, and prevents mechanical cell damage caused by repeated medium exchange.

(3) Pan-Nucleic-Acid Transfection Compatibility

Serving as an all-in-one transfection tool, it supports the delivery of DNA, RNA and RNAi molecules to satisfy diverse experimental demands: DNA for vector construction and gene editing, RNA for expression regulation, and RNAi for gene silencing assays. It performs stably in both single-nucleic-acid transfection and multi-molecule co-transfection, providing one-stop transfection solutions.

(4) Broad Cell Compatibility

Compatible with hundreds of cell types, the reagent covers multiple research directions: it supports fibroblast (3T3, COS-7) transfection for tissue regeneration research; works for myoblasts (C2C12, L6 CRL-1458) to study muscle development; enables hepatocyte (HepG2, HuH7) gene assays for liver disease research; fits hematological tumor models (K562 erythroleukemia cells) and lung cancer cell lines (A549, NCI-H460) for oncological mechanism exploration and therapeutic target screening.

(5) Streamlined Experimental Workflow

With standardized, user-friendly operating steps, PGbioFect 3000Plus requires no complicated pretreatment or professional technical skills. It lowers experimental thresholds, reduces human-operation-induced errors, and improves overall laboratory efficiency.

5. High Cost-Effectiveness for Long-Term Laboratory Usage

For common cell lines, PGbioFect 3000Plus delivers higher transfection efficiency with lower working dosage. The 1.5 mL specification supports up to 1,500 independent transfection reactions in 24-well plates. It cuts direct reagent costs for large-scale experiments including drug screening and gDNA library construction. Furthermore, its low failure rate reduces repeated experimental spending, maximizing research investment returns for academic laboratories and biotech enterprises.

Conclusion

Equipped with proprietary nanoparticle technology, T3000 transfection enhancer, comprehensive cellular adaptability and economic benefits, PGbioFect 3000Plus Transfection Reagent is an optimal transfection tool for biomedical researchers. It empowers reliable, cost-effective and high-throughput cell transfection experiments, and fuels innovative breakthroughs in life science research.